These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12414643)

  • 1. Conditionally replicative adenovirus expressing p53 exhibits enhanced oncolytic potency.
    van Beusechem VW; van den Doel PB; Grill J; Pinedo HM; Gerritsen WR
    Cancer Res; 2002 Nov; 62(21):6165-71. PubMed ID: 12414643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
    Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
    J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
    Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
    Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
    Oosterhoff D; Pinedo HM; Witlox MA; Carette JE; Gerritsen WR; van Beusechem VW
    Gene Ther; 2005 Jun; 12(12):1011-8. PubMed ID: 15729367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death.
    Abou El Hassan MA; van der Meulen-Muileman I; Abbas S; Kruyt FA
    J Virol; 2004 Nov; 78(22):12243-51. PubMed ID: 15507611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.
    van Beusechem VW; Mastenbroek DC; van den Doel PB; Lamfers ML; Grill J; Würdinger T; Haisma HJ; Pinedo HM; Gerritsen WR
    Gene Ther; 2003 Nov; 10(23):1982-91. PubMed ID: 14528322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy.
    Idema S; Lamfers ML; van Beusechem VW; Noske DP; Heukelom S; Moeniralm S; Gerritsen WR; Vandertop WP; Dirven CM
    J Gene Med; 2007 Dec; 9(12):1046-56. PubMed ID: 17966130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy.
    Lam JT; Kanerva A; Bauerschmitz GJ; Takayama K; Suzuki K; Yamamoto M; Bhoola SM; Liu B; Wang M; Barnes MN; Alvarez RD; Siegal GP; Curiel DT; Hemminki A
    J Gene Med; 2004 Dec; 6(12):1333-42. PubMed ID: 15493039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of a conditionally replicative adenovirus agent to human squamous cell carcinomas of the head and neck.
    Zhu ZB; Mathis JM; Makhija SK; Lu B; Wang M; Ji S; Rivera AA; Rosenthal EL; Siegal GP; Curiel DT
    Int J Oncol; 2007 Nov; 31(5):1213-22. PubMed ID: 17912450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase-dependent oncolytic adenovirus for cancer treatment.
    Huang TG; Savontaus MJ; Shinozaki K; Sauter BV; Woo SL
    Gene Ther; 2003 Aug; 10(15):1241-7. PubMed ID: 12858189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effect.
    Mitlianga PG; Sioka C; Vartholomatos G; Goussia A; Polyzoidis K; Rao JS; Kyritsis AP
    Oncol Rep; 2006 Jan; 15(1):149-53. PubMed ID: 16328048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer.
    Heideman DA; Steenbergen RD; van der Torre J; Scheffner M; Alemany R; Gerritsen WR; Meijer CJ; Snijders PJ; van Beusechem VW
    Mol Ther; 2005 Dec; 12(6):1083-90. PubMed ID: 16085463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2.
    van Beusechem VW; van den Doel PB; Gerritsen WR
    Mol Cancer Ther; 2005 Jun; 4(6):1013-8. PubMed ID: 15956259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
    Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
    Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacy.
    Oosterhoff D; van Beusechem VW
    J Exp Ther Oncol; 2004 Apr; 4(1):37-57. PubMed ID: 15255291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.
    Carette JE; Graat HC; Schagen FH; Abou El Hassan MA; Gerritsen WR; van Beusechem VW
    J Gene Med; 2005 Aug; 7(8):1053-62. PubMed ID: 15756711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
    Steegenga WT; Riteco N; Bos JL
    Oncogene; 1999 Sep; 18(36):5032-43. PubMed ID: 10490840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.